Table 2.
Univariate analysis | Multivariable analysis | |||
---|---|---|---|---|
Co-efficient (95% CI) |
p value | Co-efficient (95% CI) |
p value | |
Age | 0.25 (0.02 to 0.47) |
0.029 | 0.33 (0.11 to 0.55) |
0.004 |
Gender | −2.57 (−7.60 to 2.46) |
0.316 | −2.74 (−7.67 to 2.19) |
0.274 |
Number of previous injections | −0.27 (−1.0 to 0.45) |
0.457 | −0.63 (−1.35 to 0.09) |
0.085 |
Systemic diagnosis | ||||
Diabetes mellitus | 0.34 (−4.98 to 5.67) |
0.899 | 1.56 (−3.72 to 6.85) |
0.561 |
Hypertension | −0.83 (−5.59 to 3.94) |
0.733 | 0.71 (−4.15 to 5.58) |
0.773 |
CKD | −5.97 (−17.27 to 5.32) |
0.299 | −3.07 (−14.37 to 8.22) |
0.593 |
Baseline SBP | −0.25 (−0.38 to −0.12) |
<0.001 | −0.28 (−0.42 to −0.15) |
<0.001 |
Ocular diagnosis | ||||
BRVO | 0.36 (−6.3 to 7.0) |
0.915 | 8.77 (−4.2 to 21.8) |
0.185 |
CNVM | −0.04 (−6.2 to 6.1) |
0.989 | 8.43 (−4.3 to 21.2) |
0.194 |
CRVO | −2.19 (−9.1 to 4.7) |
0.531 | 6.58 (−6.6 to 19.7) |
0.325 |
NPDR | 3.78 (−1.9 to 9.4) |
0.189 | 11.38 (−1.1 to 23.9) |
0.075 |
NVG | 4.25 (−9.0 to 17.5) |
0.530 | 12.57 (−4.8 to 30.0) |
0.156 |
PCV | −8.85 (−20.5 to 2.8) |
0.137 | – | – |
PDR | −1.26 (−7.0 to 4.5) |
0.667 | −7.48 (−5.1 to 20.0) |
0.242 |
BRVO, branch retinal vein occlusion; CI, confidence interval; CKD, chronic kidney disease; CNVM, choroidal neovascular membrane; CRVO, central retinal vein occlusion; NPDR, nonproliferative diabetic retinopathy; NVG, neovascular glaucoma; PCV, polypoidal choroidal vasculopathy; PDR, proliferative diabetic retinopathy; SBP, systolic blood pressure.
The significant values have been written in italics.